Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGetech Grp Regulatory News (GTC)

Share Price Information for Getech Grp (GTC)

Share Price is delayed by 15 minutes
Get Live Data
2.15    0.00 (0.00%)
Bid:
2.00
Ask:
2.30
Spread: 0.30 (15.00%)
Market Cap: £3.28m
GTC Live PriceLast checked at - London Stock Exchange

Intraday Getech Grp Share Chart

Director/PDMR Shareholding

22 Jul 2013 16:01

RNS Number : 8712J
GETECH Group plc
22 July 2013
 



Getech Group plc

 

("Getech" or the "Company")

 

Directors Dealings

 

The Company has issued 794,681 ordinary shares following the exercise of options by Raymond Wolfson and Paul Markwick, both directors of the Company and by an employee.

 

Raymond Wolfson exercised options over 540,000 ordinary shares at a price of 20p per Ordinary Share and Paul Markwick exercised options over 229,149 Ordinary Shares of which 19,149 ordinary shares were exercised at a price of 9.87p and 210,000 ordinary shares were exercised at a price of 15p.

 

The employee exercised options over 25,532 Ordinary Shares.

 

At the same time, the Company has received notice that Raymond Wolfson has sold 190,000 ordinary shares at a price of 65.5p per ordinary share to cover the cost of the exercise of the options (of which 85,000 ordinary shares were sold on 19 July 2013 and 105,000 Ordinary Shares were sold on 22 July 2013) and that Paul Markwick has sold 80,000 ordinary shares at a price of 65.5p per ordinary shares, for the same reason (of which 65,000 ordinary shares were sold on 19 July 2013 and 15,000 Ordinary Shares were sold on 22 July 2013).

 

Raymond Wolfson now holds 400,000 ordinary shares representing 1.33% of the issued shares in the Company and Paul Markwick holds 172,553 ordinary shares representing 0.57% of the issued share capital of the Company.

 

Accordingly, application has been made for 794,681 ordinary shares to be admitted to trading on AIM, and dealings are expected to commence on 26 July 2013.

 

Following the issue of these new shares, the number of Ordinary Shares in issue will increase to 30,101,117. For the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules ("DTRs"), the issued ordinary share capital of the Company following this allotment consists of 30,101,117 Shares with voting rights attached (one vote per Share). There are no Shares held in treasury. This total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in, Getech under the DTRs.

 

For further information, please contact:

 

GETECH Group plc

Raymond Wolfson, Chief Executive

 

 

Tel: 0113 322 2200

WH Ireland Limited

Katy Mitchell

 

Tel: 0161 832 2174

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSNKBDKPBKDKOB
Date   Source Headline
2nd Jun 202611:30 amRNSResult of AGM
22nd May 20267:00 amRNSDirectorate change
8th May 20267:00 amRNSNotice of AGM
30th Apr 20267:00 amRNSFinal Results
28th Apr 202610:15 amRNSNotice of Results and Investor Meeting
8th Apr 202611:15 amRNSHolding(s) in Company
31st Mar 20267:00 amRNSMajor Globe Platform Subscription Renewal
21st Jan 20261:00 pmRNSHolding(s) in Company
20th Jan 20267:00 amRNSTrading Statement
31st Oct 20252:30 pmRNSHolding(s) in Company
30th Oct 20257:00 amRNSMultiple Contract Wins
28th Oct 20259:45 amRNSHolding(s) in Company
2nd Oct 20254:30 pmRNSHolding(s) in Company
29th Sep 202512:15 pmRNSHolding(s) in Company
24th Sep 20257:00 amRNSHalf-year Report
10th Sep 202510:40 amRNSHolding(s) in Company
20th Aug 20257:00 amRNSDirectorate Change
24th Jul 20257:00 amRNSTrading Statement
9th Jul 20255:30 pmRNSHolding(s) in Company
25th Jun 20257:00 amRNSFormation of Hydrogen JV
11th Jun 20251:52 pmRNSDirector/PDMR Shareholding
4th Jun 20254:45 pmRNSHolding(s) in Company
2nd Jun 20259:15 amRNSHolding(s) in Company
29th May 20254:15 pmRNSResult of AGM
29th May 20257:00 amRNSMajor Globe Platform Subscription Renewal
8th May 20257:00 amRNSGrant of Share Options
6th May 202512:15 pmRNSHolding(s) in Company
6th May 20257:00 amRNSFinal Results
21st Mar 202512:55 pmRNSHolding(s) in Company
21st Mar 202512:45 pmRNSHolding(s) in Company
27th Feb 20257:00 amRNSCompletion of Property Sale
4th Feb 20257:00 amRNSSale of Nicholson House
23rd Jan 20257:00 amRNSBoard Changes & Leadership Transition
20th Jan 20259:30 amRNSHolding(s) in Company
20th Jan 20257:00 amRNSTrading Update
17th Jan 202510:00 amRNSHolding(s) in Company
17th Dec 20249:00 amRNSHolding(s) in Company
2nd Dec 20245:30 pmRNSHolding(s) in Company
2nd Dec 202412:15 pmRNSHolding(s) in Company
29th Nov 202410:40 amRNSHolding(s) in Company
8th Nov 20249:31 amRNSExercise of Share Options
1st Nov 20245:18 pmRNSDirector/PDMR Shareholding
28th Oct 20247:00 amRNSHydrogen Collaboration Agreement
17th Oct 20247:00 amRNSExercise of Share Options
10th Oct 202410:35 amRNSHolding(s) in Company
8th Oct 20249:45 amRNSDirectorate Change
23rd Sep 20247:00 amRNSHalf-year Report
13th Sep 202410:42 amRNSHolding(s) in Company
29th Aug 20245:00 pmRNSHolding(s) in Company
29th Aug 20243:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.